Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...
VERU Inc. (VERU) $24. High Risk, Minimal Reward?
Pre-FDA Approval Play. The Shares Are Now in the Hands of Fast Money Traders.
You Can't Kiss all the...
Adding Alkaline Water (WTER) to 2022 Beverage Watch List at $0.46, More Names Coming.
The Alkaline Water Company (WTER). Identifies $15 Million in Cost Savings and Margin Enhancements.
With nearly $200 million...
What is NAC (N-Acetyl-L-Cysteine)? (Dr Eric Berg)
https://youtu.be/oPdGOrqTfhA
What is NAC good for? (and How Much to Take?)
Chula Vista Scamster Gets Pinched
Great detective work by the SEC on this. If you ever wonder how/why your stock or stock you're following drops from $1.00...
Revive Therapeutics (RVVTF) Enters the Danger Zone.
What Danger You Ask?
Danger #1, the FDA doesn't like the data, and you own the stock.
Adding Provention Bio (PRVB) $4.60 to 2022 Biotech Watch List.
This is in our 'Stocks we Hope to Double' Watch List.
LIVE QUOTE
AI and Machine Learning Start-Up Nowigence (NWGO) Announces Deal With EquiPPP Technologies (NSE: EQIPPP).
Nowigence CEO Anoop Bhatia was voted most innovative AI NLP Company CEO 2020.With over two decades in various GE companies across different...
Bill Hwang Had $20 Billion, Then Lost It All in Two Days (Bloomberg).
With all the news on leveraged Bitcoin blowups being reported, let's not forget leverage can blowup an Equity portfolio too. Forgotten in...
Provention (PRVB) Price Target $18.
Headline Says Downgrade, But That's Near 300% Higher From Here!
LIVE QUOTE